Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Design Therapeutics (DSGN) Return on Equity (2020 - 2026)

Design Therapeutics' Return on Equity history spans 2 years, with the latest figure at 0.0% for Q4 2021.

  • On a quarterly basis, Return on Equity fell 1.0% to 0.0% in Q4 2021 year-over-year; TTM through Dec 2021 was 0.0%, a 1.0% decrease, with the full-year FY2021 number at 0.0%, changed N/A from a year prior.
  • Return on Equity hit 0.0% in Q4 2021 for Design Therapeutics, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for DSGN hit a ceiling of 0.01% in Q4 2020 and a floor of 0.0% in Q4 2021.